Lee A. Surkin, MD, MS, FACC, FCCP, FASNC, FAASM is triple board certified in cardiology, sleep medicine, and nuclear cardiology. Dr. Surkin completed his internal medicine residency at Yale-New Haven Hospital and fellowship in cardiovascular medicine at Yale University School of Medicine. He is president and founder of CardioSleep Diagnostics, founder of the American Academy of Cardiovascular Sleep Medicine and president of Empire Sleep Medicine in NYC.
With over 24 years of clinical practice, Dr. Surkin created a new paradigm in cardiovascular disease treatment. His unique and effective practice model for patient care emphasizes comprehensive wellness with a multi-faceted approach to prevention, early detection, and aggressive management by incorporating sleep with cardiovascular and obesity medicine. In addition to advising physicians, dentists and corporations, Dr Surkin offers virtual care to patients across the US with multiple state licenses.
Dr. Surkin established the American Academy of Cardiovascular Sleep Medicine, a not-for-profit academic organization dedicated to an interdisciplinary approach to education, supporting clinical and academic research and furthering public awareness of the strong association between cardiovascular disease and sleep disorders.
Dr. Surkin is a co-author of the seminal manuscript; Cardiovascular Disorders in Narcolepsy: Review of associations and determinants and co-author of the soon to be published textbook CPAP Adherence – Factors and Perspectives. Dr. Surkin is an editor of Sleep Review Magazine and has been highlighted in the New York Times for High-Tech Alternatives to High-Cost Care.
He is a Fellow of the American College of Cardiology, Fellow of the College of Chest Physicians, Fellow of the American Society of Nuclear Cardiology, Fellow of the American Academy of Sleep Medicine and recipient of numerous awards and recognitions.
Subscribe to "The Monthly Beat" Newsletter
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.